Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay. Ever wondered how toxic psychoactive drugs that have been shown to be clinically insignificant have been catapulted into multi-billion dollar blockbuster sellers despite the fact that these drugs pose serious safety risks?
USA Today: Conflicts of Interest Bedevil Psychiatric Drug Research
Reading Time: < 1 minute
Recent Posts
- Obesity’s Epigenetic Memory: Unravelling the Molecular Mechanisms Underlying Weight Loss Resistance November 20, 2024
- Bridging Gut and Brain Health: The Role of Probiotics, Nutraceuticals, and Neuronutrition in Human Health and Recovery November 5, 2024
- A Healthy Gut is… October 24, 2024
- The Role of Food Ingredients in the Induction of Oral Tolerance and IgA October 10, 2024
- Menopausal Transition: A Review for Health Care Practitioners September 25, 2024
Recent Comments
- Claire Tozer on AFMCP Europe 2025 – Blended Online and In-Person
- Anna Tillotson on AFMCP Europe 2025 – Blended Online and In-Person
- Clare Stannard on Turning Conflict into Connection in Clinic with Advanced Empathy Skills with Dr Tom Gedman
- Mark on CPD WEBINAR: Whole Child Medicine with BG Mancini
Tags
A(H1N1)
allergies
anti-aging
antibiotics
antioxidants
autism
autoimmune
bacteria
brain
CAM
cancer
cardiovascular
coeliac
cytokines
depression
detoxification
diet
dysbiosis
EFAs
evidence
gut
gut health
IBD
IBS
immune
immunity
inflammation
Lifestyle
microbiome
microbiota
mucosal
nutrition
obesity
pandemic
prevention
probiotics
regulatory T cells
research
sleep
swine flu
treatment
virus
Vitamin A
vitamin D
vitamins